Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort

Metabolic abnormalities have been associated with olanzapine treatment. We assessed if olanzapine has dose‐dependent effects on metabolic parameters with changes for weight, blood pressure, lipid and glucose profiles being modelled using linear mixed‐effects models. The risk of metabolic abnormaliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoretsanitis, Georgios, Dubath, Céline, Grosu, Claire, Piras, Marianna, Laaboub, Nermine, Ranjbar, Setareh, Ansermot, Nicolas, Crettol, Séverine, Vandenberghe, Frederik, Gamma, Franziska, von Gunten, Armin, Plessen, Kerstin Jessica, Seifritz, Erich, Conus, Philippe, Eap, Chin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305461/
https://www.ncbi.nlm.nih.gov/pubmed/35150056
http://dx.doi.org/10.1111/bcpt.13715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305461/
https://www.ncbi.nlm.nih.gov/pubmed/35150056
http://dx.doi.org/10.1111/bcpt.13715

Ejemplares similares